JBIO
Jade Biosciences, Inc.
NASDAQ: JBIO · HEALTHCARE · BIOTECHNOLOGY
$24.40
+9.32% today
Updated 2026-04-30
Market cap
$1.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$7 – $28
Volume
0.6M
Jade Biosciences, Inc. (JBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-7.86M | $-27.40M | $-39.12M | $-56.78M | $-71.20M | $-94.69M |
| Capital expenditures | $0.00 | $181000.00 | $195000.00 | $142000.00 | $0.00 | $196000.00 |
| Depreciation | $1000.00 | $15000.00 | $68000.00 | $96000.00 | $282000.00 | — |
| Stock-based comp | — | — | — | — | $2512.00 | $20.01M |
| Free cash flow | $-7.86M | $-27.58M | $-39.32M | $-56.92M | $-71.20M | $-94.89M |
| Investing cash flow | — | $-113.43M | $6.93M | $11.88M | $56.03M | — |
| Financing cash flow | $8.92M | $190.46M | $396000.00 | $46.00M | $25.43M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |